Pharma Journalist -

Ironwood Pharmaceuticals, Inc. and Allergan plc announced positive topline data from a Phase IIIb clinical trial evaluating LINZESS (linaclotide) 290 mcg on multiple abdominal symptoms…
Read More...

ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics and a market leader in automated cellular processing, today announced that it has received Health Canada approval of…
Read More...

Premier Inc. and Pensiamo Inc. have partnered to launch a new pharmaceutical supply chain solution that was co-developed with UPMC, a world-renowned healthcare provider and insurer.…
Read More...

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping into the power…
Read More...

Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek (entrectinib) for the treatment of adult and paediatric patients with neurotrophic…
Read More...

Voyager Therapeutics announced a restructuring of its gene therapy relationship with Sanofi Genzyme. Under the terms of the agreement, Voyager gains worldwide rights to the VY-HTT01…
Read More...

Lyophilization Services of New England (LSNE) announced the acquisition of a sterile injectables manufacturing facility located in León, Spain. The site, LSNE-León, will complement…
Read More...

Boehringer Ingelheim and OSE Immunotherapeutics SA announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a…
Read More...

Halo Labs Inc. is pleased to announce that it has entered into a non-binding letter of intent (LOI) for the proposed acquisition of Bophelo Bioscience & Wellness (Pty) Ltd…
Read More...

CASI Pharmaceuticals, Inc. a U.S. biopharmaceutical company that is focusing on developing and accelerating the launch of innovative therapeutics and pharmaceutical products in China,…
Read More...